IJCOPE Journal

UGC Logo DOI / ISO Logo

International Journal of Creative and Open Research in Engineering and Management

A Peer-Reviewed, Open-Access International Journal Supporting Multidisciplinary Research, Digital Publishing Standards, DOI Registration, and Academic Indexing.
Journal Information
ISSN: 3108-1754 (Online)
Crossref DOI: Available
ISO Certification: 9001:2015
Publication Fee: 599/- INR
Compliance: UGC Journal Norms
License: CC BY 4.0
Peer Review: Double Blind
Volume 02, Issue 01

Published on: January 2026

DEVELOPMENT AND CHARACTERIZATION OF NANO-BASED DRUG DELIVERY SYSTEMS FOR POORLY SOLUBLE DRUGS

Sneha R. Pawar Rahul S. More

Dr. Mahesh T. Borse

Department of Pharmaceutical Analysis
Shree Lakshmi College of Pharmacy

Article Status

Plagiarism Passed Peer Reviewed Open Access

Available Documents

Abstract

Poor aqueous solubility remains a significant challenge in pharmaceutical development, affecting nearly 40% of marketed drugs and over 70% of new chemical entities. Traditional formulation strategies frequently fail to deliver the desired bioavailability, leading to therapeutic inefficiencies. Nano-based drug delivery systems (NDDS) have emerged as a transformative approach to enhance the solubility, stability, and bioavailability of poorly soluble compounds. This research article comprehensively explores the design, development, and characterization of various NDDS — including nanoparticles, nanocrystals, solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), nanoemulsions, and polymeric micelles — tailored for poorly water-soluble drugs. Through a detailed literature review, materials and methods, in-depth analysis of characterization techniques, and critical evaluation of outcomes, this article highlights how NDDS can improve drug dissolution, pharmacokinetics, targeted delivery, and therapeutic efficacy. The outcomes demonstrate that nano-formulations significantly enhance solubility and bioavailability compared to traditional formulations. Challenges and limitations such as scale-up, physiological barriers, and regulatory considerations are also examined. Finally, future perspectives on clinical translation pathways are discussed, underscoring the potential of NDDS to revolutionize drug delivery for poorly soluble drugs.

How to Cite this Paper

Pawar, S. R. & More, R. S. (2026). Development and Characterization of Nano-Based Drug Delivery Systems for Poorly Soluble Drugs. International Journal of Creative and Open Research in Engineering and Management, <i>02</i>(01), 1-9. https://doi.org/10.55041/ijcope.v2i1.005

Pawar, Sneha, and Rahul More. "Development and Characterization of Nano-Based Drug Delivery Systems for Poorly Soluble Drugs." International Journal of Creative and Open Research in Engineering and Management, vol. 02, no. 01, 2026, pp. 1-9. doi:https://doi.org/10.55041/ijcope.v2i1.005.

Pawar, Sneha, and Rahul More. "Development and Characterization of Nano-Based Drug Delivery Systems for Poorly Soluble Drugs." International Journal of Creative and Open Research in Engineering and Management 02, no. 01 (2026): 1-9. https://doi.org/https://doi.org/10.55041/ijcope.v2i1.005.

Search & Index

References

1.               Babu, N. J., Nangia, A. (2011). Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals. Crystal Growth & Design, 11(7), 2664–2672.


2.               Gao, L., Zhang, D., Chen, M., & Yuan, H. (2013). Drug nanocrystals: in vivo performances. Journal of Controlled Release, 160(3), 418–430.


3.               Pouton, C. W. (2006). Nanoemulsions as drug delivery systems: recent developments and future prospects. Advanced Drug Delivery Reviews, 58(15), 1795–1826.


4.               Sahana, D. K., Mittal, G., Bhardwaj, V., & Rastogi, S. (2008). Nanotechnology in ocular drug delivery: present and future. Current Drug Delivery, 5(3), 295–306.


5.               Singh, A., & Lillard, J. W. Jr. (2009). Nanoparticle-based targeted drug delivery. Experimental and Molecular Pathology, 86(3), 215–223.


6.               Ma, W., Li, J., Li, X., Bai, Y., & Liu, H. (2021). Nanostructured Substrates as Matrices for Surface Assisted Laser Desorption/Ionization Mass Spectrometry: A Progress Report from Material Research to Biomedical Applications. Small Methods, 5(10), 2100762. https://doi.org/10.1002/smtd.202100762


7.               Wang, X., Xia, J., Yang, L., Dai, J., & He, L. (2023). Recent progress in exosome research: isolation, characterization and clinical applications. Cancer Gene Therapy, 30(8), 1051–1065. https://doi.org/10.1038/s41417-023-00617-y


8.               Thommes, M., & Cychosz, K. A. (2014). Physical adsorption characterization of nanoporous materials: progress and challenges. Adsorption, 20(2–3), 233–250. https://doi.org/10.1007/s10450-014-9606-z


9.               Belete, T. M. (2022). Recent Progress in the Development of Novel Mycobacterium Cell Wall Inhibitor to Combat Drug-Resistant Tuberculosis. Microbiology Insights, 15, 117863612210998. https://doi.org/10.1177/11786361221099878


Özdemir, O., & Kopac, T. (2022). Recent Progress on the Applications of Nanomaterials and Nano-Characterization Techniques in Endodontics: A Review. Materials, 15(15), 5109. https://doi.org/10.3390/ma15155109

Ethical Compliance & Review Process

  • All submissions are screened under plagiarism detection.
  • Review follows editorial policy.
  • Authors retain copyright.
  • Peer Review Type: Double-Blind Peer Review
  • Published on: Jan 26 2026
CCBYNC

This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. You are free to share and adapt this work for non-commercial purposes with proper attribution.

View License
Scroll to Top